Shares of Johnson & Johnson /zigman2/quotes/201724570/composite JNJ -0.34% slipped 1.06% to $160.20 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX -0.23% falling 2.80% to 3,639.66 and Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA -0.32% falling 2.11% to 29,296.79. This was the stock's third consecutive day of losses. Johnson & Johnson closed $26.49 below its 52-week high ($186.69), which the company achieved on April 25th.
The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Roche Holding AG Part. Cert. /zigman2/quotes/206948568/composite RHHVF +1.72% fell 0.01% to $335.57, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK -0.29% rose 0.18% to $87.60, and Pfizer Inc. /zigman2/quotes/202877789/composite PFE +0.23% fell 1.79% to $42.32. Trading volume (6.4 M) remained 899,451 below its 50-day average volume of 7.3 M.